Highlights of the 2nd European Lung Cancer Conference.
The Second European Lung Cancer Conference was held in Geneva, Switzerland from 28 April to 1 May 2010, under the cosponsorship of the International Association for the Study of Lung Cancer and the European Society for Medical Oncology. The main topics included: tobacco control, which represents a crucial challenge for thoracic oncologists; personalized medicine, consisting of the identification of driver genetic alterations in patients' tumors before tailoring targeted treatment against these molecular alterations; and current developments of radiotherapy, including improvement of techniques, combination with third- or fourth-generation cytotoxic agents, and increased quality control. Overall, the conference provided lung cancer specialists with an up-to-date comprehensive overview of the most significant advances in research and treatment and enhanced multidisciplinary interactions between physicians and researchers worldwide.
Girard
Nicolas
N
Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France; UMR 754, Claude Bernard University, Lyon, France.
Mornex
Françoise
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000532:radiotherapy; D008495:Medical Oncology / Q000639:trends; D015272:Pulmonary Medicine / Q000639:trends; D020266:Radiotherapy, Conformal / Q000379:methods; D000074606:Smoking Prevention; D012955:Societies, Medical; D057170:Translational Research, Biomedical / Q000639:trends